T. Rowe Price Associates

T. Rowe Price Associates’s Verona Pharma VRNA Stock Holding History

T. Rowe Price Associates’s Portfolio VRNA Stock Details VRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$169M	Sell
2025 Q1	$118M	Buy
2024 Q4	$85.2M	Buy
2024 Q3	$38.4M	Buy
2024 Q2	$13.7M	Buy